Mylan N.V. (MYL) Announces Launch of First Generic of Brevibloc Injection in Single-Dose Bags
Tweet Send to a Friend
Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Esmolol Hydrochloride in Sodium Chloride Injection, 2,500 mg/250 mL (10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
